Gene Dosage-Dependent Effects of Cardiac-Specific Overexpression of the A 3 Adenosine Receptor
- 26 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 91 (2) , 165-172
- https://doi.org/10.1161/01.res.0000028007.91385.ee
Abstract
We used a genetic approach to determine whether increasing the level of A3 adenosine receptors (A3ARs) expressed in the heart confers protection against ischemia without causing cardiac pathology. ...Keywords
This publication has 27 references indexed in Scilit:
- A novel cardioprotective role of RhoA: new signaling mechanism for adenosineThe FASEB Journal, 2001
- Targeted Deletion of the A3Adenosine Receptor Confers Resistance to Myocardial Ischemic Injury and does not Prevent Early PreconditioningJournal of Molecular and Cellular Cardiology, 2001
- Ischemic preconditioningPharmacology & Therapeutics, 2000
- Signaling Pathways for Cardiac Hypertrophy and FailureNew England Journal of Medicine, 1999
- Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failureJournal of Clinical Investigation, 1999
- Gq Signaling in Cardiac Adaptation and MaladaptationTrends in Cardiovascular Medicine, 1999
- Relative Importance of Adenosine A1and A3Receptors in Mediating Physiological or Pharmacological Protection from Ischemic Myocardial Injury in the Rabbit HeartJournal of Molecular and Cellular Cardiology, 1998
- Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart.Journal of Clinical Investigation, 1996
- Direct preconditioning of cultured chick ventricular myocytes. Novel functions of cardiac adenosine A2a and A3 receptors.Journal of Clinical Investigation, 1996
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994